CClinicalTrials.gg
CompletedNCT02484976BASIC-FMRIUpdated Sep 6, 2018

Brain Activation and Satiety in Children: Functional Magnetic Resonance Imaging

An interventional study of Family Based Behavioral Treatment in Childhood Obesity, sponsored by Seattle Children's Hospital. Completed at 1 site in United States. Open to participants aged 9 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-06.

Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
81
Allocation
Not applicable
Ages
9 Years to 11 Years
Sex
All
01

Study summary

BASIC fMRI is a prospective single center intervention trial using fMRI imaging in 9-11 year old obese male and females pre and post family-based behavioral treatment of 24 weeks duration to determine the relationship between impulsivity and central satiety responses.

Read the detailed description

The high prevalence of childhood obesity in the U.S. demands a better understanding of factors that drive weight gain and influence the outcome of pediatric obesity interventions. This project investigates the hypothesis that, as in adults, a subset of obese children experience a diminished satiety response to food consumption, and that these children are more resistant to gold standard family-based behavioral treatment (FBT) for obesity. FBT is targeted almost exclusively toward parents; however, there is evidence that obesity development and response to intervention may depend on additional factors such as individual internal satiety perception and variability in the function of brain centers associated with impulsivity and reward. The proposed research uses functional magnetic resonance imaging (fMRI) to characterize brain function related to satiety and examines fMRI along with behavioral, cognitive, and hormonal testing to fully examine potential mediators of children's experience of satiety and response to FBT. The approach is based on evidence that failure to attenuate the reward value of palatable foods after eating can be a manifestation of a blunted central satiety response that is reliably detected using fMRI. Key objectives will be to determine if differences in the central satiety response exist between obese and non-obese children, and, among obese children, if the strength of the central satiety response is associated with impulsivity and/or the success of obesity treatment. The central hypothesis is that, in obese children, a blunted central nervous system satiety response impairs the success of obesity interventions. To achieve study objectives, brain activation by high-calorie visual food cues before and after food consumption will be measured by fMRI. Participants will be obese and non-obese children aged 9-11 years. The 49 obese children will be evaluated before and after they participate in a 6-month evidence-based FBT intervention. Their pre-intervention fMRI will be compared to those of 20 non-obese controls to test for a blunted central satiety response (Aim 1). The relationship of impulsivity to satiety responses and food intake will be determined in obese children (Aim 2). The longitudinal component tests whether central satiety responses prior to treatment predict treatment outcomes (Aim 3A) and whether changes in central satiety responses during treatment predict maintenance of reduced weight 6 and 12 months after treatment cessation (Aim 3B). Behavioral, cognitive, and hormonal measures will be examined as potential mediating or confounding factors contributing to fMRI responses. The proposed research is guided by an integrated, transdisciplinary team with expertise in pediatric and adult neuroimaging, appetite regulation, and family-based childhood obesity treatment. This research will provide new insights into the neurobiological basis of child obesity and the relevance of neurobiological factors to treatment success. The long-term objective is to translate these findings to improve obesity interventions cost-effectively and sustain better long-term results.

During years 1-3, obese children will be enrolled into intervention groups of 9-11 families with staggered start dates by 3-6 months. Years 1-4 includes enrollment, intervention, longitudinal follow-up, and data collection for obese children. Control children will primarily be recruited during years 2-3 to facilitate matching. FMRI scans are processed on a rolling basis as studies are completed. In years 3 and 4 hormonal assays will be performed. Final data analyses will be completed in year 4.

02

Conditions studied

  • Childhood Obesity

Keywords

  • Family Based Behavioral Treatment
  • functional magnetic resonance imaging (fMRI)
  • Childhood Obesity
  • Satiety
  • BMI z-score
  • Impulsive
  • Non-obese controls
  • Visual food cues
  • Leptin
  • Hormones
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 81 is close to the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Seattle Children's Hospital is the lead sponsor of 210 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 9-11 years of age
  • Male or female
  • Ability and willingness to participate in study visits including fMRI scans and blood draws;
  • ability to provide informed written consent and assent;
  • BMI z-score for lean control children 15th to 84.9th perc. for age and sex,
  • BMI z-score for obese children BMI z-score >90th perc. for age and sex;
  • Additional inclusion criteria for obese children: One overweight parent (BMI >25 kg/m2); willingness of 1 parent (does not have to be the obese parent) to engage in family-based weight control treatment.

Exclusion criteria

Exclusion Criteria:

  • History of acute or chronic serious medical conditions;
  • known diabetes mellitus or recent (6 mo.) history of anemia;
  • presence of any implanted metal or metal devices, including ferro-metallic surgical clips or braces;
  • claustrophobia;
  • documented cognitive disorder, disruptive behavior, inability to participate in group sessions;
  • current use of medications known to alter appetite, body weight, or brain response (e.g. anti-seizure medications, glucocorticoids, medications for attention deficit disorder);
  • food intolerance or vegetarianism.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
81 participants (actual)

Study arms

  • Experimental
    Family Based Behavioral Treatment

    Central satiety brain and hormonal responses will be compared pre-and post-Family Based Behavioral Treatment, as well, as to a non-obese sample.

    Behavioral: Family Based Behavioral Treatment

Interventions

  • BehavioralFamily Based Behavioral Treatment

    Obese children accompanied by at least one parent or caregiver will attend 24 weekly in-person sessions. Sessions will include 25-30 min. meetings between an interventionist and each child/parent pair to individualize treatment, followed by separate child and parent group meetings lasting 40 - 45 min. Parents will serve as primary agents of change for their child and for themselves. Training will focus on food and physical activity education, parenting around food and physical activity, and use of behavioral skills (e.g., self-monitoring, environmental control, contingency management). Intervention groups of 9-11 children/families will be initiated every 3-6 mos. in study yrs. 1-3.

06

What researchers measure

Primary outcomes

  1. Blunted central satiety response measured by functional magnetic resonance imaging

    Time frame: Baseline

Secondary outcomes

  1. Change of brain response to visual food cues or eating behavior measured by functional magnetic resonance imaging

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  2. Relationship between impulsivity and satiety in obese children as measured by functional magnetic resonance imaging.

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  3. Relationship between impulsivity and satiety in obese children as measured by the Relative Reinforcing Value of Food (RRV).

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  4. Relationship between impulsivity and satiety in obese children as measured by the Developmental NEuroPSYchological Assessment (NEPSY).

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  5. Relationship between impulsivity and satiety in obese children as measured by the Delayed Choice Questionnaire (DCQ).

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

Other outcomes

  1. Predictors of treatment outcomes measured by functional magnetic resonance imaging.

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  2. Predictors of treatment outcomes measured by behavioral skills use questionnaires.

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

  3. Predictors of treatment outcomes measured by hormonal measures.

    Time frame: Change from pre- to post-treatment (end of 6 month intervention)

07

Study locations

1 site
  • Seattle Childrens Hospital
    Seattle, Washington 89105, United States
08

References and documents

Publications

  • Saelens BE, Melhorn SJ, Rowland MG, Scholz K, De Leon MRB, Elfers CT, Schur EA, Roth CL. General and Food-Specific Impulsivity and Inhibition Related to Weight Management. Child Obes. 2022 Mar;18(2):84-91. doi: 10.1089/chi.2021.0080. Epub 2021 Aug 5. PubMed 34357785 ↗
  • Roth CL, Melhorn SJ, Elfers CT, Scholz K, De Leon MRB, Rowland M, Kearns S, Aylward E, Grabowski TJ, Saelens BE, Schur EA. Central Nervous System and Peripheral Hormone Responses to a Meal in Children. J Clin Endocrinol Metab. 2019 May 1;104(5):1471-1483. doi: 10.1210/jc.2018-01525. PubMed 30418574 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02484976
Lead sponsor
Seattle Children's Hospital
Collaborators
University of Washington
Responsible party
Christian Roth (Christian Roth, MD, Seattle Children's Hospital) — Principal investigator
First posted
Jun 30, 2015
Start date
Sep 2014
Primary completion
Jul 2018
Completion
Aug 2018
Last update
Sep 6, 2018

Study contacts

Christian Roth, MD
principal investigator · Seattle Children's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion